Viibryd vs. Escitalopram

See how Viibryd and Escitalopram compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Viibryd is a newer SPARI antidepressant with a partial 5-HT1A agonist mechanism, while escitalopram is a well-established SSRI available as a low-cost generic.

  • Both carry a boxed warning for increased suicidal thoughts in children, teens, and young adults, and both require gradual titration over one to two weeks.

  • Escitalopram treats both depression and generalized anxiety and is approved for adolescents, while Viibryd is approved only for adult depression and must be taken with food.

Viibryd vs. Escitalopram Drug Summary

Viibryd

Viibryd (vilazodone) is a serotonin partial agonist and reuptake inhibitor (SPARI) approved to treat major depressive disorder in adults. It combines serotonin reuptake inhibition with partial activation of 5-HT1A receptors, a mechanism different from standard SSRIs. It's taken once daily with food, starting at 10 mg and titrating up to a 40 mg maintenance dose.

Escitalopram

Escitalopram is a selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder in adults and adolescents 12 to 17, as well as generalized anxiety disorder in adults. It's taken once daily, starting at 10 mg for the first week before increasing to a 20 mg maintenance dose.

Viibryd vs. Escitalopram Side Effects

Viibryd

Most common
nausea (up to 23%)
insomnia (6% to 7%)
diarrhea (up to 28%)
vomiting (up to 5%)

Escitalopram

Most common
nausea (up to 15%)
insomnia (up to 9%)
ejaculation disorder (up to 9%)
fatigue (up to 8%)

Viibryd vs. Escitalopram Dosage

Viibryd

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Days 1-7
Maximum dose 40 mg once daily Day 15 onward
Dose changes 2 increases Every 7 days

Escitalopram

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Week 1
Maximum dose 20 mg once daily Week 2 onward
Dose changes 1 increase Every week

Viibryd vs. Escitalopram Indications

Viibryd

Viibryd is FDA-approved to treat major depressive disorder in adults. It has not been studied or approved for use in children or teens. Because food significantly boosts its absorption, it must be taken with a meal every day.

  • FDA-approved for major depressive disorder in adults

  • Not approved for pediatric depression

  • Must be taken with food for proper absorption

  • No FDA approval for anxiety disorders

Escitalopram

Escitalopram is FDA-approved for major depressive disorder in both adults and adolescents ages 12 to 17, as well as generalized anxiety disorder in adults. It is not approved for bipolar depression or for children under 12. Its broader age and diagnosis range make it a common first-line choice.

  • FDA-approved for MDD in adults and teens 12-17

  • FDA-approved for generalized anxiety disorder in adults

  • Not approved for bipolar depression

  • Available as tablet or oral solution

Viibryd vs. Escitalopram Pros and Cons

Viibryd

Viibryd's dual mechanism sets it apart from standard SSRIs, but it comes with a strict food requirement and a much higher price tag since no affordable generic exists. Insurance coverage can be inconsistent given its brand-only status.

Pros

  • Additional non-SSRI mechanism (5-HT1A partial agonism) may help when SSRIs alone haven't worked

  • Some trial data suggest lower sexual side effect rates than typical SSRIs

  • Partial 5-HT1A agonist activity may add anxiolytic benefit beyond typical SSRI action, based on its receptor pharmacology

Cons

  • Must be taken with food or absorption drops significantly

  • No affordable generic available, keeping cost high (roughly $380 to $650 per month)

  • Higher rates of GI side effects like diarrhea and nausea

Escitalopram

Escitalopram is a well-studied, inexpensive generic with FDA approval for both depression and anxiety, including in teens. Its side effect profile is typical for SSRIs, including sexual dysfunction, but it lacks Viibryd's distinct receptor mechanism.

Pros

  • FDA-approved for both depression and generalized anxiety disorder

  • Approved for adolescents 12-17 with depression

  • Widely available as a low-cost generic (roughly $8 to $56 per month)

Cons

  • Higher reported rates of sexual side effects, like ejaculation disorder

  • Standard SSRI mechanism may not help patients who haven't responded to SSRIs

  • Fewer alternative options if SSRI class effects are intolerable

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.